Published in Eur J Pharmacol on December 01, 1977
Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol (1989) 4.96
The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology (1999) 3.78
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol (1971) 2.17
Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther (1973) 2.05
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science (1997) 2.01
Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry (1996) 1.89
Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci U S A (1996) 1.66
Acceleration of noradrenaline biosynthesis in the guinea-pig vas deferens by potassium. Br J Pharmacol (1970) 1.64
Pharmacokinetics of nevirapine: initial single-rising-dose study in humans. Antimicrob Agents Chemother (1993) 1.62
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat New Biol (1973) 1.61
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.55
Selective reduction of tryptophan hydroxylase activity in rat forebrain after midbrain raphe lesions. Brain Res (1971) 1.54
The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res (1990) 1.45
Choline: selective accumulation by central cholinergic neurons. J Neurochem (1973) 1.45
Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease. Exp Neurol (1997) 1.43
Susceptibility to a parkinsonian toxin varies during primate development. Exp Neurol (2012) 1.41
Fetal neural graft survival. Lancet (1990) 1.40
Comment on Roth appliance. Am J Orthod Dentofacial Orthop (1993) 1.39
Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys. Exp Neurol (1999) 1.38
Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci (1996) 1.38
Variations in noradrenaline output with respect to stimulus frequency, train length and origin of the transmitter. Br J Pharmacol (1972) 1.32
Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci (2000) 1.30
Pharmacology of mesocortical dopamine neurons. Pharmacol Rev (1983) 1.27
Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology (1997) 1.25
Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep". Biochem Pharmacol (1970) 1.24
Acceleration of noradrenaline biosynthesis by nerve stimulation. Life Sci (1966) 1.23
Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience (1984) 1.22
Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther (1972) 1.21
Variation in noradrenaline output with changes in stimulus frequency and train length: role of different noradrenaline pools. Br J Pharmacol (1974) 1.19
Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry (1975) 1.17
In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther (1998) 1.16
The action of reserpine on noradrenaline biosynthesis in sympathetic nerve tissue. Biochem Pharmacol (1968) 1.16
Catecholamine metabolism, depressive illness, and drug response. Arch Gen Psychiatry (1972) 1.14
Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology (2001) 1.13
The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience (1999) 1.13
Telencephalic projections of the A8 dopamine cell group. Ann N Y Acad Sci (1988) 1.13
Autoreceptor regulation of dopamine synthesis. Ann N Y Acad Sci (1990) 1.12
Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci (1991) 1.10
The predator odor, TMT, displays a unique, stress-like pattern of dopaminergic and endocrinological activation in the rat. Brain Res (2000) 1.09
Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J Neurosci (1996) 1.09
Functional occlusion for the orthodontist. J Clin Orthod (1981) 1.09
Distinct regional and subcellular localization of adenylyl cyclases type 1 and 8 in mouse brain. Neuroscience (2007) 1.08
Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res (1990) 1.07
Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action. Prog Brain Res (2000) 1.07
Content and release of amino-acids and catecholamines in monkey brain. Nature (1969) 1.06
Gamma-hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy. J Pharmacol Exp Ther (1970) 1.06
Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet (1986) 1.06
Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience (2000) 1.05
Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci Lett (1989) 1.05
Evidence that central nervous system depression by 1,4-butanediol in mediated through a metabolite, gamma-hydroxybutyrate. Biochem Pharmacol (1968) 1.04
The straight-wire appliance 17 years later. J Clin Orthod (1987) 1.04
Light and heavy norepinephrine storage particles in the rat heart and in bovine splenic nerve. J Pharmacol Exp Ther (1968) 1.02
D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey. J Pharmacol Exp Ther (1991) 1.02
Increased turnover of norepinephrine in the rat cerebral cortex during stress: role of the locus coeruleus. Neuropharmacology (1973) 1.02
GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry (1980) 1.02
Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. J Pharmacol Exp Ther (1973) 1.01
Evidence for involvement of protein kinase in the activation by adenosine 3':5'-monophosphate of brain tyrosine 3-monooxygenase. J Biol Chem (1975) 1.01
An antisense oligonucleotide reverses the footshock-induced expression of fos in the rat medial prefrontal cortex and the subsequent expression of conditioned fear-induced immobility. J Neurosci (1999) 1.01
Behavioral effects of stimulation of the nucleus locus coeruleus in the stump-tailed monkey Macaca arctoides. Brain Res (1976) 1.00
Factors influencing the rate of norepinephrine biosynthesis in nerve tissue. J Pharmacol Exp Ther (1967) 1.00
Regulation of catecholamine synthesis in the rat brain in vitro by cyclic AMP. Nature (1974) 1.00
Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology (Berl) (1988) 1.00
Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. Eur J Pharmacol (1976) 0.99
Effect of anesthetic doses of hydroxybutyrate on subcortical concentrations of homovanillic acid. Eur J Pharmacol (1971) 0.98
Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra. Brain Res (1985) 0.97
Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys. Eur J Pharmacol (1991) 0.97
Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychopharmacology (1997) 0.97
Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn Schmiedebergs Arch Pharmacol (1976) 0.96
Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization. J Pharmacol Exp Ther (2000) 0.96
TMT, a predator odor, elevates mesoprefrontal dopamine metabolic activity and disrupts short-term working memory in the rat. Brain Res Bull (2000) 0.96
Adenosine triphosphate--metal--norepinephrine ternary complexes and catecholamine binding. Nature (1965) 0.96
Postmortem stability of monoamines, their metabolites, and receptor binding in rat brain regions. J Neurochem (1994) 0.95
Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions. Neuroscience (1989) 0.95
Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors. Commun Psychopharmacol (1979) 0.95
Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus). Neuroscience (1997) 0.95
Enhanced release of transmitter during sympathetic nerve stimulation in the presence of angiotensin. Br J Pharmacol (1969) 0.94
Angiotensin accelerates catecholamine biosynthesis in sympathetically innervated tissues. Nature (1969) 0.93
Diverse spore rains and limited local exchange shape fern genetic diversity in a recently created habitat colonized by long-distance dispersal. Ann Bot (2012) 0.93
Dopaminergic neurons: effects of electrical stimulation on dopamine biosynthesis. Mol Pharmacol (1976) 0.93
The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med (1987) 0.93
Characterization of dopamine release in the rat medial prefrontal cortex as assessed by in vivo microdialysis: comparison to the striatum. Neuroscience (1990) 0.93
Cocaine and cocaethylene: microdialysis comparison of brain drug levels and effects on dopamine and serotonin. J Neurochem (1993) 0.92
Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette: norepinephrine, serotonin, and dopamine. J Am Acad Child Psychiatry (1979) 0.92
Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF. J Comp Neurol (2009) 0.92
Regulation of noradrenaline biosynthesis in nerve tissue. Nature (1967) 0.92
Engagement in a non-escape (displacement) behavior elicits a selective and lateralized suppression of frontal cortical dopaminergic utilization in stress. Synapse (1999) 0.92
5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex. Neuropsychopharmacology (1999) 0.91
Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls. Exp Brain Res (1991) 0.91
Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Brain (1990) 0.91
Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys. Psychopharmacology (Berl) (1999) 0.91
Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease. Neuroscience (2011) 0.90
Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier. Behav Neurosci (1990) 0.90
Cryopreservation of human brain tissue. Exp Neurol (1990) 0.90
Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies. Brain Res (1992) 0.90
Co-ordination chemistry and membrane function with particular reference to the synapse and catecholamine transport. Nature (1965) 0.90
In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate. Synapse (1993) 0.90
Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: a return to control measures. Cell Transplant (2005) 0.90
Formation and regional distribution of gamma-hydroxybutyric acid in mammalian brain. Biochem Pharmacol (1970) 0.90